Vanda Pharmaceuticals (VNDA) Tops Q4 EPS by 15c
Tweet
Share
E-mail
Get Alerts VNDA Hot Sheet
Price: $5.33 +2.11%
Financial Fact:
Cost of sales, product: 6.99M
Today's EPS Names:
MSGM, SMID, VISL, More
Financial Fact:
Cost of sales, product: 6.99M
Today's EPS Names:
MSGM, SMID, VISL, More
Join SI Premium – FREE
Vanda Pharmaceuticals (NASDAQ: VNDA) reported Q4 EPS of $0.03, $0.15 better than the analyst estimate of ($0.12). Revenue for the quarter came in at $44.3 million versus the consensus estimate of $43.45 million.
Sees combined net product sales from both HETLIOZ® and Fanapt® $180 to $200 million
For earnings history and earnings-related data on Vanda Pharmaceuticals (VNDA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Freightos Limited (CRGO) Tops Q2 EPS by 3c ; Offers Guidance
- UBS: 'We Believe Dollar Tree (DLTR) is Turning From a Transformation to a Growth Story'
- Yum! Brands (YUM) PT Lowered to $180 at Argus
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
